Abstract
Some samples of human growth hormone used as therapy until the mid-1980s contain amyloid-β peptide and cause genetically modified mice to develop amyloid-β deposits in the brain.
| Original language | English |
|---|---|
| Pages (from-to) | 354-355 |
| Number of pages | 2 |
| Journal | Nature |
| Volume | 564 |
| Issue number | 7736 |
| DOIs |
|
| State | Published - Dec 20 2018 |
Keywords
- Alzheimer's disease
- Neurodegeneration